You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
NO
YES
  1. CORPORATE - 20-03-2020

    Letter to patient associations and scientific organizations

    Communication from Paolo Marcucci, Chairman & CEO of Kedrion

    read more 
  2. FEATURED STORIES - 04-01-2020

    In memory of Fabrizio Fabbrizzi

    Written by: Albert Farrugia

    read more 
  3. EVENTS - 25-11-2019

    Kedrion alongside IPOPI at the IPIC Congress in Madrid

    The importance of early diagnosis and the most recent innovations in the treatment of PID patients were the focus

    read more 
  4. EVENTS - 15-11-2019

    Kedrion keeps Hemophilia therapy debate flowing in Latin America

    A recent CLAHT Congress symposium restates current and future role of replacement therapy

    read more 

Pages

For more information please contact: pressoffice@kedrion.com